Synchron is a pioneering company in the field of neural interface technology. They specialize in developing brain-computer interfaces (BCIs) that are designed to help individuals with severe paralysis restore their ability to communicate and interact with digital devices. Their flagship product, the "Stentrode," is an endovascular BCI that is implanted via the blood vessels, minimizing invasive brain surgery. This innovative approach allows for the translation of neural signals into command signals for external devices, offering new communication possibilities for patients with neurological conditions.